导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 35.20% | 101/1050 |
| 近一周 | -1.89% | 356/1104 |
| 近一月 | -8.54% | 956/1102 |
| 近一季 | 27.61% | 15/1092 |
| 近半年 | 27.78% | 86/1070 |
| 近一年 | 18.23% | 259/1018 |
| 近两年 | 46.69% | 526/926 |
| 近三年 | 22.19% | 471/834 |
| 成立以来 | 47.62% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
12.50% 24/1070 |
11.66% 523/1101 |
- - |
- - |
| 2025 | 1.97% 916/1065 |
-0.50% 828/1014 |
0.15% 668/1038 |
16.77% 702/1050 |
-12.37% 938/1065 |
| 2024 | -15.15% 861/1011 |
-10.09% 774/960 |
-4.91% 628/983 |
11.88% 462/991 |
-11.29% 934/1011 |
| 2023 | -19.76% 665/952 |
0.65% 599/880 |
-13.07% 830/895 |
-9.52% 570/915 |
1.36% 82/952 |
| 2022 | -14.35% 158/867 |
-13.06% 174/773 |
2.11% 662/806 |
-15.10% 575/845 |
13.63% 46/867 |
| 2021 | 16.44% 180/740 |
-1.61% 208/580 |
22.85% 123/659 |
-0.49% 221/704 |
-3.19% 549/740 |
| 2020 | 81.98% 85/554 |
12.74% 32/419 |
40.59% 21/466 |
8.40% 294/517 |
5.91% 421/554 |
| 2019 | 36.22% 252/410 |
24.30% 760/1149 |
-2.58% 558/1231 |
12.05% 79/390 |
0.40% 385/410 |
| 2018 | -19.34% 64/349 |
- - |
- - |
- - |
-11.54% 482/1080 |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票A | 0.8316 | 54.00% |
| 招商前沿医疗保健股票C | 0.7978 | 53.53% |
| 招商医药健康产业股票 | 2.5730 | 49.25% |
| 广发医药精选股票C | 1.2923 | 40.43% |
| 广发医药精选股票A | 1.3132 | 38.48% |
| 嘉实医疗保健股票 | 2.5780 | 38.47% |
| 前海开源公共卫生股票A | 0.4690 | 37.42% |
| 前海开源公共卫生股票C | 0.4590 | 37.30% |
| 中欧医疗创新股票A | 1.6444 | 34.01% |
| 中欧医疗创新股票C | 1.5481 | 33.74% |
| 建信高端医疗股票A VS. 东吴新产业精选股票A(580008) |